Neuromagen Pharma

NeuroMagen Pharma is developing a novel drug that boosts the effectiveness of telomerase as a neuroprotector in order to delay the onset and progression of ALS.

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Technologies
Company Founded Year
Company Number of Employees
Neuromagen Pharma
02/07/2022
NeuroPharmacology | NeuroBioTechnology
Biotechnology & Biopharmaceutical
Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis)
Biochemical: pharmacological drugs (Developing drugs)
01/01/2021
"1-10"